EPS for Walgreens Boots Alliance, Inc. (WBA) Expected At $1.53

March 10, 2018 - By Louis Casey

 EPS for Walgreens Boots Alliance, Inc. (WBA) Expected At $1.53

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.53 EPS on April, 4.They anticipate $0.17 EPS change or 12.50 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.52B giving it 11.54 P/E if the $1.53 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 19.53 % EPS growth. The stock increased 2.36% or $1.63 during the last trading session, reaching $70.6. About 4.00 million shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 11, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. The firm has “Market Perform” rating by Raymond James given on Wednesday, September 27. Morgan Stanley downgraded the shares of WBA in report on Friday, October 6 to “Equal-Weight” rating. The stock has “Buy” rating by RBC Capital Markets on Friday, February 16. Credit Suisse maintained the shares of WBA in report on Monday, November 16 with “Outperform” rating. Jefferies maintained the shares of WBA in report on Wednesday, June 21 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Monday, October 17. The company was maintained on Thursday, October 29 by S&P Research. The firm earned “Outperform” rating on Monday, October 31 by Wells Fargo. Robert W. Baird maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on Thursday, January 4 with “Buy” rating. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) earned “Buy” rating by UBS on Wednesday, August 23.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $69.94 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 19.48 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More notable recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: Nasdaq.com which released: “Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for February …” on February 13, 2018, also Zacks.com with their article: “Should Value Investors Pick Walgreens Boots Alliance (WBA) Stock?” published on February 27, 2018, Seekingalpha.com published: “Walgreens Boots Alliance appoints James Kehoe Global CFO” on March 08, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) were released by: Blogs.Wsj.com and their article: “CFO Moves: Walgreens Boots Alliance” published on March 09, 2018 as well as Chicagotribune.com‘s news article titled: “Amerisource shares jump on Walgreens buyout report” with publication date: February 13, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: